Enavatuzumab, a Humanized Anti-TWEAK Receptor Monoclonal Antibody, Exerts Antitumor Activity through Attracting and Activating Innate Immune Effector Cells.

Autor:	Ye, Shiming1, Fox, Melvin I.1, Belmar, Nicole A.1, Sho, Mien1, Chao, Debra T.1, Choi, Donghee1, Fang, Yuni1, Zhao, Vivian1, Keller, Stephen F.1, Starling, Gary C.2, Culp, Patricia A.3
Zdroj:	Journal of Immunology Research. 9/17/2017, p1-14. 14p. 1 Color Photograph, 1 Chart, 5 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu